Identification Of The Molecular Hallmarks Of Naevi Progressing To Melanoma
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
Melanomas are amongst the most commonly occurring cancers in Australia with >136,000 people living with a previous melanoma diagnosis. One of the highest risk factors for developing melanoma is having a high number of moles (or naevi). It is therefore important to fully understand how and why naevi develop into melanoma. It is hoped that early detection markers will be identified which will help identify early melanomas and as such improve patient outcome.
Quantitative Proteomic Analysis Of Faecal Biomarkers For Colon Cancer
Funder
National Health and Medical Research Council
Funding Amount
$562,398.00
Summary
We have identified a number of potential biomarkers present in the stools of patients with colorectal cancer (CRC). We will use quantitative mass spectrometric techniques that we have developed to validate these biomarkers on a large number of faecal samples from patients with CRC and multiple control groups. We believe these studies will lead to a new panel of biomarkers which will improve the detection of early forms of colon cancer, thus reducing death from this disease.
Randomized Controlled Trial Of A Video-delivered Intervention For The Early Detection Of Melanoma In Men 50+ Years
Funder
National Health and Medical Research Council
Funding Amount
$511,694.00
Summary
Unfortunately, men over 50 years are most at risk to die from melanoma. Skin self-examination, where a man inspects the skin of his whole body with the help of a mirror or another person, and rapid presentation to a doctor without delay if he detects a suspicious lesion has the potential to increase awareness for the skin and to improve early diagnosis. We want to assess if we can increase the rate of skin self-examination in men 50 years and over through a video-delivered intervention.
Prospective Methylation Biomarker Validation Study In Lung Cancer
Funder
National Health and Medical Research Council
Funding Amount
$528,281.00
Summary
Lung cancer is a major public health burden with increasing incidence every year. Despite advances, the biology of lung cancer associated with its recurrence either local or distant, with non-smoking lung cancer subtypes and asbestos-related lung cancer remains unexplored.
Early Detection And Early Intervention For Cerebral Palsy
Funder
National Health and Medical Research Council
Funding Amount
$2,088,220.00
Summary
Cerebral Palsy (CP) is Australia’s 5th expensive health condition. Early Detection and effective early interventions are vitally needed to improve long-term outcomes. This fellowship develops and tests novel interventions to optimise neuroplasticity by improving early detection and physical, cognitive, psychological and health outcomes in children with CP. Earlier accurate detection of CP will ensure effective treatments utilise critical periods of brain development.
Enabling Personalised Risk Assessment For Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Bowel cancer screening will be most effective in disease prevention if it is applied proportionately to individual person's risk. Risk-based screening requires a risk calculator to assess personal risk. By utilising existing large, international datasets, I will identify the risk factors specific for different bowel cancer types and incorporate them to upgrade the prediction model that I have developed. This will achieve more accurate risk prediction to enable personalised risk-based screening.
Peer Delivered Early Intervention For Infants At High Risk Of Cerebral Palsy In Indigenous Australia
Funder
National Health and Medical Research Council
Funding Amount
$286,891.00
Summary
This study explores the effectiveness of early detection and intervention for infants at risk of cerebral palsy in Indigenous Australia. Infants will be detected by 3 months, and randomly assigned to one of two intervention groups; home-based peer-delivered multi-domain intervention, or health advice. Infants receiving the novel intervention are expected to have improved developmental outcomes, and caregivers improved mental health.
Development Of Effective Biomarkers For The Diagnosis And Prognosis Of Prostate Cancer
Funder
National Health and Medical Research Council
Funding Amount
$1,062,585.00
Summary
Every year ~20,000 Australian men are diagnosed with prostate cancer and more than 3,000 die of this disease. The current PSA test for the diagnosis of prostate cancer is not specific and this can result in incorrect diagnosis, unnecessary biopsies and lead to wrong treatments. We have discovered a novel change in the biology of prostate cancer. We will use this information to develop new tests for prostate cancer, which provide early accurate detection and can predict disease progression.
Long Term Outcomes Of Infant Lung Function In Cystic Fibrosis
Funder
National Health and Medical Research Council
Funding Amount
$509,456.00
Summary
We have shown that babies with cystic fibrosis (CF) who are apparently well can still have lung problems. As lung disease is the major cause of death in CF we need ways to monitor the condition in babies, identify those at greatest risk of lung changes and predict which children should receive newer treatments. We have developed a unique program for the measurement of lung function in babies. We now aim to find out the long term consequences of lung function changes detected in infants with CF.
DImensional Attention MOdelling For Neglect Detection (DIAMOND): A Novel Application For Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$513,483.00
Summary
One in three people experience neglect disorder after brain injury, where half of their visual world appears missing. Neglect is a persistent and distressing cognitive problem impacting all aspects of daily life, and is typically under-diagnosed and poorly treated. We have built a novel 3D technology platform for precision detection of neglect, and for informing personalised treatment options. This systematic feasibility project will establish early evidence for advanced neglect assessment.